Corcept Therapeutics (CORT) Operating Income (2010 - 2026)
Corcept Therapeutics (CORT) reported Operating Income of $41.3 million for Q2 2026, up 54.8% from $26.68 million a year earlier.
Corcept Therapeutics (CORT) Operating Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Corcept Therapeutics' Operating Income came in at $6.41 million, down 93.7% year-over-year; for FY2025, it was $44.8 million, down 67.3% from FY2024.
- Operating Income has a five-year compound annual growth rate of -19.0% (FY2020 to FY2025).
- By year, Operating Income came in at $136.95 million in FY2024 (+27.7%), $107.28 million in FY2023 (-4.8%), $112.63 million in FY2022 (-9.5%) and $124.48 million in FY2021 (-2.9%).
- The Q2 2026 figure ranks as the highest quarterly Operating Income since Q3 2024.
- Year over year, Operating Income gained in two of the last seven quarters, with an average decline of 27.1%.
- The high point for year-over-year Operating Income in five years was Q1 2024 (growth of 98.6%); the low point was Q1 2025 (a decline of 88.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$49.6 million (Q1 2026), $4.49 million (Q4 2025) and $10.22 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Corcept Therapeutics | 12.56 Bn | 11.12 Bn | 252.09 Mn | 41.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.30 Mn |
| Mar 31, 2026 | -49.60 Mn |
| Dec 31, 2025 | 4.49 Mn |
| Sep 30, 2025 | 10.22 Mn |
| Jun 30, 2025 | 26.68 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 25.26 Mn |
| Sep 30, 2024 | 46.60 Mn |
| Jun 30, 2024 | 35.59 Mn |
| Mar 31, 2024 | 29.50 Mn |
| Dec 31, 2023 | 31.67 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Jun 30, 2023 | 29.58 Mn |
| Mar 31, 2023 | 14.85 Mn |
| Dec 31, 2022 | 22.50 Mn |
| Sep 30, 2022 | 31.93 Mn |
| Jun 30, 2022 | 31.43 Mn |
| Mar 31, 2022 | 26.77 Mn |
| Dec 31, 2021 | 36.66 Mn |
| Sep 30, 2021 | 36.23 Mn |
Corcept Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=CORT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();